Fathom Therapeutics: Valuation, Funding & Investors
Fathom Therapeutics is an early-stage biotechnology company that combines quantum chemistry and artificial intelligence to design novel small-molecule drugs. The company focuses on physics-driven, AI-enabled prediction of molecule behavior inside living cells to accelerate discovery and develop next-generation medicines.
Leadership & Board
- Current Number of Employees
- 23
- Current LinkedIn Followers
- 2,202
Latest Estimated Valuation
- Total Amount Raised
- $47M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $47M
- Latest Funding Round
- Series A
Employee Trend
Fathom Therapeutics had 23 employees as of October 26, 2026. The number of employees increased by 0 (0.00%) week-over-week.
23Latest Employee Count
0(0.00%)Week-Over-Week Change
Social Trend
Fathom Therapeutics had 2,202 followers as of October 26, 2026. The number of followers increased by 60 (2.80%) week-over-week.
2,202Latest Followers Count
60(2.80%)Week-Over-Week Change
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Apr 27, 2026 | Series A | $47.00M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| Sutter Hill Ventures | Series A |
| Chemistry | Series A |
| Alexandria Venture Investments | Series A |
| Empire State Development's NY Ventures | Series A |
Similar Companies
A snapshot of private companies similar to Fathom Therapeutics, helping you discover and navigate related company profiles.
